Á¤¸Æ³» ¿ä¹ý ¹× Á¤¸Æ ¾×¼¼½º ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2025-2033
»óǰÄÚµå : 1675388
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 144 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Á¤¸Æ³» ¿ä¹ý¡¤Á¤¸Æ ¾×¼¼½º ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 263¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ÀÌ ½ÃÀåÀÌ 395¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³âÀÇ ¼ºÀå·ü(CAGR)Àº 4.4%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ ¸¸¿¬, ±³Åë»ç°íÀÇ Áõ°¡, Á¡Àû ¿ä¹ýÀÇ ÀÌÁ¡¿¡ °üÇÑ ¼ÒºñÀÚ ÀǽÄÀÇ Çâ»óÀÌ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

Á¤¸Æ³» ¿ä¹ýÀº Á¤¸ÆÀ» ÅëÇØ Ç÷·ù¿¡ Á÷Á¢ ¼öºÐ, ¾à¹°, ¿µ¾çÀ» Åõ¿©ÇÏ´Â ÀÇ·á ½Ã¼úÀÔ´Ï´Ù. ÀÌ ½Ã¼úÀº ´Ù¾çÇÑ Áõ»ó°ú Áúº´À» Ä¡·áÇϱâ À§ÇØ º´¿ø, Áø·á¼Ò, ±âŸ ÀÇ·á ½Ã¼³¿¡¼­ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¤¸Æ Á¢±ÙÀº Á¤¸Æ³» Ä¡·á¸¦ À§ÇØ Á¤¸ÆÀ¸·Î µé¾î°¡´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÀÇ·á Àü¹®°¡´Â ÀϹÝÀûÀ¸·Î ¹Ù´ÃÀ» »ç¿ëÇÏ¿© ÇǺθ¦ ¶Õ°í Á¤¸Æ¿¡ Á¢±ÙÇÏÁö¸¸, Á¤¸ÆÀÌ °¡´Ã°Å³ª ¼Õ»óµÈ Á¤¸Æ, Å»¼ö, ºñ¸¸ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÀϺΠȯÀÚ¿¡°Ô´Â ¾î·Á¿òÀÌ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ¼ö¾×¿ä¹ý¿¡´Â ¿©·¯ À¯ÇüÀÌ Àִµ¥, Å»¼öÁõ¿¡ ´ëÇÑ ½Ä¿°¼ö, °¨¿°¿¡ ´ëÇÑ Ç×»ýÁ¦, ¾Ï Ä¡·á¿¡ ´ëÇÑ È­Çпä¹ý µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´À» Ä¡·áÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó ¿¹¹æÁ¢Á¾À̳ª ºñŸ¹Î Åõ¿© µî ¿¹¹æÀû Àǹ̷εµ ¼ö¾×¿ä¹ýÀ» ½ÃÇàÇÏ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù.

Á¤¸Æ³» Ä¡·á ¹× Á¤¸Æ Á¢±Ù ½ÃÀå µ¿Çâ :

¾Ï, ´ç´¢º´, ÀÚ°¡¸é¿ªÁúȯ µî Àå±âÀûÀÎ Åõ¾à°ú ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ ¹× »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡°¡ Á¤¸Æ³» Ä¡·á ¹× Á¤¸Æ Á¢±Ù ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ±³Åë»ç°í ¹ß»ý·ü Áõ°¡¿Í ¿Ü»ó »ç·ÊÀÇ ±ÞÁõµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤¸Æ³» Ä¡·á ¹× Á¤¸Æ Á¢±ÙÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ÁßÁõ ȯÀÚ Ä¡·á Áõ°¡´Â ½ÃÀå¿¡ À¯ÀÍÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ¿Í ÇÔ²² ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ º¯È­Çϰí ÀÖ´Â °Íµµ Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, ½Ã°£°ú ³ë·ÂÀ» ÁÙÀ̰í, °¨¿° À§ÇèÀ» ³·Ã߸ç, ½Ã¼úÀÇ Á¤È®¼ºÀ» Çâ»ó½ÃŰ´Â ÀÇ·á »ê¾÷ÀÇ ¼ö¸¹Àº ±â¼ú ¹ßÀüÀº ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² »õ·Î¿î Ä¡·á¹ý, ¾àǰ, ±â±â Çõ½ÅÀ» À§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ÅõÀÚ°¡ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·áºñ ÁöÃâ Áõ°¡, º´¿ø ¼ö Áõ°¡, ÀçÅÃÄ¡·áÀÇ º¸±Þ, ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ Á¤¸Æ³» ¿ä¹ý¡¤Á¤¸Æ ¾×¼¼½º ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦10Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global intravenous (IV) therapy and vein access market size reached USD 26.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

Intravenous (IV) Therapy and Vein Access Market Trends:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

Key Market Segmentation:

Type Insights:

Application Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Intravenous (IV) Therapy and Vein Access Market

6 Market Breakup by Type

7 Market Breakup by Application

8 Market Breakup by End User

9 Market Breakup by Region

10 Drivers, Restraints, and Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â